•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A00901 Summary:

BILL NOA00901A
 
SAME ASSAME AS S01267-A
 
SPONSORMcDonald
 
COSPNSRSteck, Stirpe, Santabarbara, Thiele, Hevesi, Burdick, Beephan, Norris, Brown K, Colton, Bendett, Gunther, Paulin, Seawright, Levenberg, Lavine, Lunsford, Ardila, Cook, Reyes, Meeks, Sayegh, Jacobson, Simpson, Davila, Lupardo, Simon, Gallahan, Raga, Weprin, Kelles
 
MLTSPNSREpstein
 
Amd §§4902 & 4903, Ins L; amd §§4902 & 4903, Pub Health L
 
Requires a utilization review agent to follow certain rules when establishing a step therapy protocol; requires that the protocol accepts any attestation submitted by the insured's health care professional stating that a required drug has failed as prima facie evidence that the required drug has failed.
Go to top